Latest Conference Articles

Laura Bush, DMSc, PA-C, DFAAPA, talks to Renata Block, MMS, PA-C, about her SDPA presidency, the future, and the importance of a positive outlook.

Poster presented at the SDPA conference reported Effisayil 2 data indicating spesolimab improved Dermatology Life Quality Index scores in patients with generalized pustular psoriasis.

Renata Block, MMS, PA-C, and Faseeha Raza, PA-C, discuss the DPAF, philanthropy, leadership, and the importance of patient care.

The JAK inhibitors have demonstrated efficacy, yet some clinicians are still wary of prescribing them. Amy Spizuoco, DO, FAOCD, shares tips to help clinicians improve their comfort in using them.

What are some of the opportunities and challenges facing PAs today? Renata Block, MMS, PA-C, shares insights and reflections on the field.

The results indicated improvement in PASI and sPGA scores as well as improvement in quality of life indicators in adults with moderate to severe psoriasis.

Researchers found dupilumab improved itch and skin lesions regardless of atopic disease status in patients with PN.

Robin Siperstein, MD, FAAD, shares practical tips in cosmetic dermatology at the 2024 SDPA Annual Summer Dermatology Meeting.

Session at the 2024 SDPA Annual Summer Dermatology Conference helps clinicians reframe beauty and empower patients.

With so many sessions and posters, there is a plethora of topics offered at this year's SDPA Summer Conference.

Catch up on a weekend full of clinical pearls from the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.

Dermatology Times asked our readers to share what conferences they are looking forward to in the second quarter of 2024.

Catch up on coverage from the last day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.

Jason Hawkes, MD, MS, detailed each of the kinases' association with different cytokine receptors and biological functions.

James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety.

Lockshin shared his approach to continuing biologic therapies into pregnancy with informed timing adjustments.

Jason Hawkes, MD, MS, breaks down boxed warning pros and cons and research addressing several boxed warnings.

The country's only double-board certified pediatric and cosmetic dermatologist shared what he learned from 5 unique patient cases this year.

James Song, MD, addressed current challenges in the AD treatment landscape and compared biologics.

Jason Hawkes, MD, MS, gives an overview of what clinicians need to know today about this rare condition.

Raj Chovatiya, MD, PhD, focused on understanding JAK inhibitors, discussing their clinical use and safety profiles for effective patient communication.

Catch up on coverage from the second day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.

Marc Serota, MD, provided clinical pearls to consider for patients on biologics, particularly dupilumab.

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

James Song, MD, discusses the current treatment landscape, genetic and immunological influences, and the role of oral minoxidil in alopecia areata.

Ben Lockshin, MD, FAAD, delves into the new generation of oral psoriasis therapies to enhance patient quality of life.

The trial results indicated 3 significant improvements across all AHFD subtypes with dupilumab treatment compared to placebo.

Catch up on coverage from the first day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.